迈瑞医疗 （300760.SZ）
239.30 +1.22（0.510%）
+ 收藏
今开：238.08 最高：239.46 成交量：1.01万手
昨收：238.08 最低：236.99 成交额：2.41亿
利润表（迈瑞医疗）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 29,484,805,493.00 | 20,530,596,799.00 | 9,372,811,209.00 | 34,931,900,884.00 | 27,303,797,964.00 | 18,475,773,496.00 | 8,364,281,841.00 |
| 营业收入(元) | 29,484,805,493.00 | 20,530,596,799.00 | 9,372,811,209.00 | 34,931,900,884.00 | 27,303,797,964.00 | 18,475,773,496.00 | 8,364,281,841.00 |
| 二、营业总成本(元) | 17,867,270,338.00 | 12,390,670,510.00 | 6,073,471,557.00 | 21,991,204,875.00 | 16,548,221,666.00 | 11,451,529,589.00 | 5,572,679,803.00 |
| 营业成本(元) | 10,358,523,254.00 | 6,928,401,101.00 | 3,190,131,192.00 | 11,820,708,329.00 | 9,251,094,921.00 | 6,356,227,937.00 | 2,810,679,041.00 |
| 研发费用(元) | 2,592,345,180.00 | 1,775,300,575.00 | 947,431,880.00 | 3,432,658,732.00 | 2,508,923,742.00 | 1,851,429,618.00 | 852,300,844.00 |
| 营业税金及附加(元) | 314,817,220.00 | 222,224,136.00 | 100,808,593.00 | 366,077,263.00 | 288,037,305.00 | 185,206,248.00 | 84,671,723.00 |
| 销售费用(元) | 3,664,616,797.00 | 2,934,958,832.00 | 1,485,484,939.00 | 5,702,924,130.00 | 3,989,365,767.00 | 2,834,582,023.00 | 1,373,819,628.00 |
| 管理费用(元) | 1,119,339,140.00 | 822,534,756.00 | 473,351,126.00 | 1,523,748,134.00 | 1,115,793,687.00 | 795,641,115.00 | 457,084,878.00 |
| 财务费用(元) | -182,371,253.00 | -292,748,890.00 | -123,736,173.00 | -854,911,713.00 | -604,993,756.00 | -571,557,352.00 | -5,876,311.00 |
| 其中：利息费用(元) | 14,197,335.00 | 9,131,150.00 | 4,465,076.00 | 12,996,889.00 | 8,818,027.00 | 5,545,091.00 | 2,600,912.00 |
| 其中：利息收入(元) | 434,205,071.00 | 316,357,754.00 | 189,758,820.00 | 821,643,445.00 | 526,335,326.00 | 292,212,391.00 | 138,435,482.00 |
| 三、其他经营收益 | |||||||
| 加：公允价值变动收益(元) | 126,883,062.00 | 126,284,421.00 | 126,027,777.00 | 79,401,838.00 | 60,837,032.00 | 33,176,206.00 | - |
| 加：投资收益(元) | 64,217,177.00 | 63,439,016.00 | -3,098,705.00 | -9,840,894.00 | -4,950,533.00 | -1,797,920.00 | -1,091,341.00 |
| 其中：对联营企业和合营企业的投资收益(元) | -14,227,425.00 | -14,114,277.00 | -3,098,705.00 | -9,816,944.00 | -5,023,888.00 | -1,542,475.00 | -1,091,341.00 |
| 资产处置收益(元) | 7,932,009.00 | 3,540,498.00 | -316,183.00 | 2,464,577.00 | 4,319,764.00 | -113,618.00 | -594,324.00 |
| 资产减值损失(元) | -161,030,640.00 | -91,139,728.00 | -43,448,954.00 | -529,505,736.00 | -120,053,114.00 | -76,853,744.00 | -42,555,992.00 |
| 信用减值损失(元) | -188,199,618.00 | -134,331,607.00 | -66,413,250.00 | -244,194,525.00 | -60,415,250.00 | -56,868,456.00 | -47,319,982.00 |
| 其他收益(元) | 627,999,117.00 | 472,471,520.00 | 260,188,187.00 | 830,836,564.00 | 565,377,484.00 | 408,181,672.00 | 199,644,189.00 |
| 四、营业利润(元) | 12,095,336,262.00 | 8,580,190,409.00 | 3,572,278,524.00 | 13,069,857,833.00 | 11,200,691,681.00 | 7,329,968,047.00 | 2,899,684,588.00 |
| 加：营业外收入(元) | 29,481,764.00 | 15,563,017.00 | 7,474,965.00 | 56,347,903.00 | 36,129,071.00 | 18,176,959.00 | 9,074,442.00 |
| 减：营业外支出(元) | 74,231,237.00 | 54,207,797.00 | 22,038,680.00 | 115,275,709.00 | 49,837,637.00 | 38,353,604.00 | 21,158,655.00 |
| 五、利润总额(元) | 12,050,586,789.00 | 8,541,545,629.00 | 3,557,714,809.00 | 13,010,930,027.00 | 11,186,983,115.00 | 7,309,791,402.00 | 2,887,600,375.00 |
| 减：所得税费用(元) | 1,347,936,867.00 | 965,607,097.00 | 395,924,083.00 | 1,432,516,623.00 | 1,351,457,445.00 | 866,578,823.00 | 315,261,372.00 |
| 六、净利润(元) | 10,702,649,922.00 | 7,575,938,532.00 | 3,161,790,726.00 | 11,578,413,404.00 | 9,835,525,670.00 | 6,443,212,579.00 | 2,572,339,003.00 |
| (一)按经营持续性分类 | |||||||
| 持续经营净利润(元) | 10,702,649,922.00 | 7,575,938,532.00 | 3,161,790,726.00 | 11,578,413,404.00 | 9,835,525,670.00 | 6,443,212,579.00 | 2,572,339,003.00 |
| (二)按所有权归属分类 | |||||||
| 归属于母公司股东的净利润(元) | 10,637,075,305.00 | 7,560,737,744.00 | 3,159,898,674.00 | 11,582,226,085.00 | 9,834,303,940.00 | 6,441,990,849.00 | 2,571,117,273.00 |
| 少数股东损益(元) | 65,574,617.00 | 15,200,788.00 | 1,892,052.00 | -3,812,681.00 | 1,221,730.00 | 1,221,730.00 | 1,221,730.00 |
| 扣除非经常性损益后的净利润(元) | 10,436,944,470.00 | 7,379,931,633.00 | 3,037,009,378.00 | 11,433,734,957.00 | 9,685,933,222.00 | 6,340,698,652.00 | 2,529,128,371.00 |
| 七、每股收益 | |||||||
| 一、基本每股收益(元) | 8.78 | 6.24 | 2.61 | 9.56 | 8.12 | 5.32 | 2.13 |
| 二、稀释每股收益(元) | 8.78 | 6.24 | 2.61 | 9.56 | 8.12 | 5.32 | 2.12 |
| 八、其他综合收益(元) | -69,484,064.00 | -135,274,601.00 | -116,262,405.00 | 272,830,698.00 | 199,121,815.00 | 322,167,973.00 | 5,136,437.00 |
| 归属于母公司股东的其他综合收益(元) | -73,077,881.00 | -133,056,042.00 | -109,942,296.00 | 271,645,344.00 | 199,121,815.00 | 322,167,973.00 | 5,136,437.00 |
| 归属于少数股东的其他综合收益(元) | 3,593,817.00 | -2,218,559.00 | -6,320,109.00 | 1,185,354.00 | - | - | - |
| 九、综合收益总额(元) | 10,633,165,858.00 | 7,440,663,931.00 | 3,045,528,321.00 | 11,851,244,102.00 | 10,034,647,485.00 | 6,765,380,552.00 | 2,577,475,440.00 |
| 归属于母公司所有者的综合收益总额(元) | 10,563,997,424.00 | 7,427,681,702.00 | 3,049,956,378.00 | 11,853,871,429.00 | 10,033,425,755.00 | 6,764,158,822.00 | 2,576,253,710.00 |
| 归属于少数股东的综合收益总额(元) | 69,168,434.00 | 12,982,229.00 | -4,428,057.00 | -2,627,327.00 | 1,221,730.00 | 1,221,730.00 | 1,221,730.00 |
| 公告日期 | 2024-10-30 | 2024-08-30 | 2024-04-27 | 2024-04-27 | 2023-10-28 | 2023-08-30 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | ||||||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 其中：利息收入(元) |
| 三、其他经营收益 |
| 加：公允价值变动收益(元) |
| 加：投资收益(元) |
| 其中：对联营企业和合营企业的投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 八、其他综合收益(元) |
| 归属于母公司股东的其他综合收益(元) |
| 归属于少数股东的其他综合收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 45 of 45 entries